Ozempic Vs Mounjaro: Complete Comparison
Mounjaro (tirzepatide) has shown superior weight loss results compared to Ozempic (semaglutide) in head-to-head clinical trials, but both medications are FDA-approved for type 2 diabetes rather than weight loss specifically.
Choosing between Ozempic and Mounjaro is one of the most common decisions our patients face at Form Blends. Both are weekly injectable medications originally designed for type 2 diabetes that also produce significant weight loss. But they are not interchangeable. They use different active ingredients, target different receptors, and produce different outcomes in clinical trials.
Let us break down exactly how these two medications compare so you can have an informed conversation with your healthcare provider.
| Feature | Ozempic | Mounjaro |
|---|---|---|
| Active Ingredient | Semaglutide | Tirzepatide |
| Drug Class | GLP-1 receptor agonist | Dual GIP/GLP-1 receptor agonist |
| FDA-Approved For | Type 2 diabetes | Type 2 diabetes |
| Manufacturer | Novo Nordisk | Eli Lilly |
| Maximum Dose | 2 mg/week | 15 mg/week |
| Administration | Weekly subcutaneous injection | Weekly subcutaneous injection |
| Average Weight Loss | ~10-14% of body weight | ~15-22% of body weight |
| List Price (monthly) | $900-$1,000/mo (brand) | $1,000-$1,200/mo (brand) |
How Ozempic Works
Ozempic contains semaglutide, a GLP-1 receptor agonist. It works by mimicking the naturally occurring hormone GLP-1, which your gut releases after meals. This hormone plays several roles in metabolism: it stimulates insulin secretion when blood sugar is high, suppresses glucagon release (which prevents your liver from dumping excess sugar into your bloodstream), slows gastric emptying, and activates appetite-suppressing pathways in the brain.
For weight loss specifically, the appetite suppression and slower gastric emptying are the primary drivers. Patients feel full sooner during meals and stay satisfied longer between them. Over time, this naturally reduces caloric intake without requiring constant willpower or calorie counting. Many patients describe this as a reduction in "food noise," the constant mental chatter about what to eat, when to eat, and how much to eat that can be exhausting for people who struggle with their weight.
Ozempic is available in doses of 0.25 mg, 0.5 mg, 1 mg, and 2 mg, given once per week via a prefilled injection pen.
How Mounjaro Works
Mounjaro contains tirzepatide, which represents a newer approach to metabolic medicine. Unlike Ozempic, which targets only the GLP-1 receptor, Mounjaro is a dual GIP/GLP-1 receptor agonist. It activates both the glucagon-like peptide-1 receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor simultaneously .
GIP is another incretin hormone that enhances insulin secretion and may also play a role in fat metabolism. By activating both receptors at once, tirzepatide appears to produce greater metabolic effects than targeting GLP-1 alone. Researchers believe this dual mechanism may explain why Mounjaro tends to produce more weight loss than single-receptor GLP-1 medications.
Mounjaro is available in doses of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, administered weekly. The wider range of doses gives prescribers more flexibility in finding each patient's optimal dose.
Efficacy Comparison: Weight Loss Results
This is where Mounjaro really stands out. The SURMOUNT-1 trial showed that patients taking the highest dose of tirzepatide (15 mg) lost an average of 22.5% of their body weight over 72 weeks . Even the middle dose (10 mg) produced average weight loss of about 19.5%. These are some of the most impressive weight loss results ever seen with a non-surgical intervention.
By comparison, semaglutide in the SUSTAIN trials produced weight loss of approximately 10-14% at the 1 mg dose over similar timeframes . While that is still clinically meaningful, it falls notably short of tirzepatide's results.
The SURPASS-2 trial directly compared tirzepatide and semaglutide 1 mg in patients with type 2 diabetes. All three tirzepatide doses (5 mg, 10 mg, and 15 mg) produced greater weight loss and better blood sugar control than semaglutide 1 mg .
It is worth noting that these comparisons used Ozempic's 1 mg dose, not the 2 mg dose that became available later. Still, most experts agree that tirzepatide's dual mechanism gives it a meaningful advantage for weight loss.
Side Effects Comparison
Both medications share a similar side effect profile, primarily gastrointestinal:
- Nausea: Common with both, especially during dose increases. Reported in roughly 15-30% of patients for each medication .
- Diarrhea: Affects approximately 10-17% of patients on either drug.
- Vomiting: More common during early titration phases.
- Constipation: Reported with both, though some studies suggest slightly higher rates with tirzepatide.
- Decreased appetite: Often listed as a side effect but is also the intended therapeutic effect for weight loss.
- Injection site reactions: Mild redness or irritation at the injection site occurs occasionally with both.
Serious side effects for both include a small risk of pancreatitis, gallbladder disease, and kidney problems . Both carry warnings about thyroid tumors based on animal data. Neither should be used by patients with a history of medullary thyroid carcinoma.
In the SURPASS-2 head-to-head trial, the overall rate of GI side effects was similar between tirzepatide and semaglutide, though the specific pattern varied slightly. Our clinical team at Form Blends helps patients manage these side effects through careful dose titration and supportive care.
Side effect management is often the difference between a patient who succeeds on these medications and one who gives up too soon. Taking the injection after a small meal, staying hydrated, eating bland foods during the first few days after a dose increase, and avoiding large fatty meals can all make a meaningful difference. Our physicians provide personalized guidance based on each patient's experience.
One notable difference between the two medications is that Mounjaro offers more dose steps (six levels from 2.5 to 15 mg) compared to Ozempic's four levels (0.25 to 2 mg). This extra granularity gives prescribers more flexibility to find the sweet spot where you are getting good weight loss results without excessive side effects.
Cost Comparison
Without insurance, both medications carry steep list prices. Ozempic runs approximately $900-$1,000/mo (brand) per month, while Mounjaro costs approximately $1,000-$1,200/mo (brand) per month.
Insurance coverage for both depends heavily on your specific plan and the prescribing indication. Since both are FDA-approved for type 2 diabetes, coverage is generally better for patients with that diagnosis. Getting coverage for off-label weight loss use can be challenging with either medication.
Manufacturer savings cards and coupons can reduce costs for some patients, but eligibility rules change frequently. For patients who find brand-name pricing prohibitive, Form Blends offers compounded semaglutide and compounded tirzepatide at significantly lower price points.
Who Is Ozempic Best For?
- Patients with type 2 diabetes who want a well-established treatment option
- Patients whose insurance covers Ozempic but not Mounjaro
- Those who prefer a medication with a longer real-world track record (Ozempic has been available since 2018)
- Patients who are responding well to semaglutide and have no reason to switch
Who Is Mounjaro Best For?
- Patients seeking maximum weight loss potential
- Those who have tried semaglutide-based medications and did not reach their goals
- Patients with type 2 diabetes who want the strongest available blood sugar control
- Those whose insurance covers Mounjaro or who can manage the out-of-pocket cost
- Patients interested in the dual-receptor approach
Frequently Asked Questions
Can I switch from Ozempic to Mounjaro?
Yes, your doctor can switch you from Ozempic to Mounjaro. Because they contain different active ingredients, you will need to start Mounjaro at the beginning of its titration schedule (2.5 mg) rather than jumping to an equivalent dose. Your doctor may adjust this based on your individual situation.
Is Mounjaro more effective than Ozempic for weight loss?
Clinical trial data consistently shows that tirzepatide (Mounjaro) produces greater average weight loss than semaglutide (Ozempic). However, individual results vary, and some patients respond very well to semaglutide. The best medication is the one that works for your body and fits your circumstances.
Are Ozempic and Mounjaro approved for weight loss?
Neither Ozempic nor Mounjaro is FDA-approved specifically for weight loss. Their weight-loss-specific counterparts are Wegovy (semaglutide) and Zepbound (tirzepatide). However, both Ozempic and Mounjaro are widely prescribed off-label for weight management.
Which has fewer side effects?
Side effect profiles are similar. Head-to-head data from the SURPASS trials did not show a clear winner in terms of tolerability. Both medications cause GI side effects, especially during the titration phase. Working with a physician who can carefully adjust your dose makes a significant difference in tolerability.
Does Form Blends offer both semaglutide and tirzepatide?
Yes. Form Blends provides physician-supervised programs using both compounded semaglutide and compounded tirzepatide. Our medical team will help determine which medication is the best fit based on your health profile and goals. Many patients start with semaglutide and transition to tirzepatide if they need stronger results, while others begin with tirzepatide from the start. We customize every treatment plan to the individual.
The choice between Ozempic and Mounjaro often comes down to what your body responds to, what your insurance covers, and how much weight you need to lose. Both are exceptional medications that have transformed the field of weight management. Neither is a wrong choice. The right choice is the one that fits your health, your goals, and your circumstances.
Wondering which medication could work best for you? Start your free consultation with Form Blends today. Our physicians will evaluate your health history, review your goals, and recommend a personalized treatment plan with access to affordable, pharmacy-compounded GLP-1 medications.